Patent ID: 7507745

Claim:
A pharmaceutical composition, comprising one or more anticholinergics of formula 1 wherein A denotes a group selected from among X—denotes an anion with a single negative charge which is selected from the group consisting of fluoride, chloride, bromide, iodide, sulphate, phosphate, methanesulphonate, nitrate, maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate and p-toluenesulphonate, R 15 denotes hydrogen, hydroxy, methyl, ethyl, —CF 3 , CHF 2 or fluorine; R 1′ and R 2′ which may be identical or different denote C 1 -C 5 -alkyl which may optionally be substituted by C 3 -C 6 -cycloalkyl, hydroxy or halogen, or R 1′ and R 2 ′ together denote a —C 3 -C 5 -alkylene-bridge; R 13 , R 14 , R 13′ and R 14′ which may be identical or different denote hydrogen, —C 1 -C 4 -alkyl, —C 1 -C 4 -alkyloxy, hydroxy, —CF 3 , —CHF 2 , CN, NO 2 or halogen, or pharmacologically acceptable acid addition salts thereof, in combination with one or more soluble TNF receptor fusion proteins (2).